[go: up one dir, main page]

UA31086A - Method for medical treatment of duodenal ulcer in setting of helicobacteriosis - Google Patents

Method for medical treatment of duodenal ulcer in setting of helicobacteriosis

Info

Publication number
UA31086A
UA31086A UA98073638A UA98073638A UA31086A UA 31086 A UA31086 A UA 31086A UA 98073638 A UA98073638 A UA 98073638A UA 98073638 A UA98073638 A UA 98073638A UA 31086 A UA31086 A UA 31086A
Authority
UA
Ukraine
Prior art keywords
helicobacteriosis
setting
medical treatment
duodenal ulcer
antihelicobacter
Prior art date
Application number
UA98073638A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Микола Миколайович Велігоцький
Николай Николаевич Велигоцкий
Віктор Васильович Комарчук
Виктор Василиевич Комарчук
Олександр Сергійович Трушин
Александр Сергеевич Трушин
Ігор Віталійович Тесленко
Игорь Виталиевич Тесленко
Микола Михайлович Кобилецький
Николай Михайлович Кобилецкий
Олена Костянтинівна Тімченко
Елена Константиновна Тимченко
Original Assignee
Харківський Інститут Удосконалення Лікарів
Харьковский институт усовершенствования врачей
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Інститут Удосконалення Лікарів, Харьковский институт усовершенствования врачей filed Critical Харківський Інститут Удосконалення Лікарів
Priority to UA98073638A priority Critical patent/UA31086A/en
Publication of UA31086A publication Critical patent/UA31086A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine. A method consists of operative intervention and antihelicobacter therapy by an antibiotic in a postoperative period. Additionally the antihelicobacter therapy is carried before and during operation. The ampicillin is used as an antibiotic in a mixture with an Almagel at a dose of 0,5 g thrice a day for 10 days before and after operations, and during operation the 40 ml 0,25 % novocaine solution with the 1,0 ampicillin is injected in the mucous membrane of antral part of stomach and duodenum.
UA98073638A 1998-07-08 1998-07-08 Method for medical treatment of duodenal ulcer in setting of helicobacteriosis UA31086A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA98073638A UA31086A (en) 1998-07-08 1998-07-08 Method for medical treatment of duodenal ulcer in setting of helicobacteriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA98073638A UA31086A (en) 1998-07-08 1998-07-08 Method for medical treatment of duodenal ulcer in setting of helicobacteriosis

Publications (1)

Publication Number Publication Date
UA31086A true UA31086A (en) 2000-12-15

Family

ID=74283150

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98073638A UA31086A (en) 1998-07-08 1998-07-08 Method for medical treatment of duodenal ulcer in setting of helicobacteriosis

Country Status (1)

Country Link
UA (1) UA31086A (en)

Similar Documents

Publication Publication Date Title
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
YU59198A (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
MX9603520A (en) Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof.
GR3035831T3 (en) Veterinary composition containing a proton pump inhibitor
HU9502174D0 (en) Aminoacid derivatives, medicaments containing these compounds and process for preparing the same
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
NO972128D0 (en) 2,2-dichloroalkanecarboxylic acids, process for their preparation, drug containing them and their use for the treatment of insulin resistance
ATE192646T1 (en) USE OF A MIXTURE OF SUBSTANCES CONTAINING ALPHA HYDROXY ORGANIC ACID FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF MINOR ORAL ULCERS
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
PL325865A1 (en) Selective antagonists of beta3-adrenergic receptor
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
ES8607916A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
UA31086A (en) Method for medical treatment of duodenal ulcer in setting of helicobacteriosis
TR199801184T2 (en) New compounds with analgesic action.
NO911508D0 (en) NEW S-TIMOLO DERIVATIVE AND PROCEDURE FOR ITS MANUFACTURING.
UA13771A (en) Method for treatment during restoration of large intestine continuity in patients with colostomy
UA50329A (en) Method for treating primary erysipelas
GR3002199T3 (en) Medicaments containing n-alkyl scopol amine salt and nitroglycerine, method for its preparation and its use
UA28922A (en) Method of treatment of the respiratory distress syndrome in adults
UA43800A (en) Method of treating the perforated ulcer of the duodenum
UA30361A (en) The method for treatment of glycoside intoxication
UA43213A (en) method for treatment of stomach and duodenal ulcerous
UA30696A (en) Method for complex treatment of periodontitis